American Heart Association: GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention med
November 02, 2026
November 02, 2026
DALLAS, Texas, Nov. 2 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention med
*
Research Highlights:
* Among more than 250,000 adults with prediabetes and obesity, those taking glucagon-like peptide-1 receptor agonists (GLP-1 medications) were about 1.5 times more likely to reverse blood sugar to normal . . .
* * *
GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention med
*
Research Highlights:
* Among more than 250,000 adults with prediabetes and obesity, those taking glucagon-like peptide-1 receptor agonists (GLP-1 medications) were about 1.5 times more likely to reverse blood sugar to normal . . .